Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
March 27, 2021
FXR in liver physiology: Multiple faces to regulate liver metabolism
Katrin Panzitt, Martin Wagner
Current Opinion in Virology
|
May 11, 2025
Ex vivo culture models to study viral infections of the liver
Esther Föderl-Höbenreich, Katrin Panzitt
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
November 26, 2020
Regulation of autophagy by bile acids and in cholestasis - CholestoPHAGY or CholeSTOPagy
Katrin Panzitt, Peter Fickert, Martin Wagner
Expert Opinion on Therapeutic Targets
|
January 26, 2019
Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention
Christiane Klec, Tony Gutschner, Katrin Panzitt, et al.
Molecular and Cellular Endocrinology
|
May 23, 2022
Recent advances on FXR-targeting therapeutics
Katrin Panzitt, Gernot Zollner, Hanns-Ulrich Marschall, et al.
Hepatology Communications
|
September 11, 2023
Hepatic farnesoid X receptor is necessary to facilitate ductular reaction and expression of heme biosynthetic genes
Angela E Dean, Emilian Jungwirth, Katrin Panzitt, et al.
Hepatology Communications
|
September 24, 2021
Meta-analysis and Consolidation of Farnesoid X Receptor Chromatin Immunoprecipitation Sequencing Data Across Different Species and Conditions
Emilian Jungwirth, Katrin Panzitt, Hanns-Ulrich Marschall, et al.
Studies in Health Technology and Informatics
|
May 24, 2019
A Comprehensive FXR Signaling Atlas Derived from Pooled ChIP-seq Data
Emilian Jungwirth, Katrin Panzitt, Hanns-Ulrich Marschall, et al.
Cancer Letters
|
November 8, 2019
MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2
Carina Seidl, Katrin Panzitt, Alexandra Bertsch, et al.
Journal of Hepatology
|
June 30, 2019
Obeticholic acid may increase the risk of gallstone formation in susceptible patients
Samer Al-Dury, Annika Wahlström, Katrin Panzitt, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
March 27, 2021
FXR in liver physiology: Multiple faces to regulate liver metabolism
Katrin Panzitt, Martin Wagner
Current Opinion in Virology
|
May 11, 2025
Ex vivo culture models to study viral infections of the liver
Esther Föderl-Höbenreich, Katrin Panzitt
Biochimica Et Biophysica Acta. Molecular Basis of Disease
|
November 26, 2020
Regulation of autophagy by bile acids and in cholestasis - CholestoPHAGY or CholeSTOPagy
Katrin Panzitt, Peter Fickert, Martin Wagner
Expert Opinion on Therapeutic Targets
|
January 26, 2019
Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention
Christiane Klec, Tony Gutschner, Katrin Panzitt, et al.
Molecular and Cellular Endocrinology
|
May 23, 2022
Recent advances on FXR-targeting therapeutics
Katrin Panzitt, Gernot Zollner, Hanns-Ulrich Marschall, et al.
Hepatology Communications
|
September 11, 2023
Hepatic farnesoid X receptor is necessary to facilitate ductular reaction and expression of heme biosynthetic genes
Angela E Dean, Emilian Jungwirth, Katrin Panzitt, et al.
Hepatology Communications
|
September 24, 2021
Meta-analysis and Consolidation of Farnesoid X Receptor Chromatin Immunoprecipitation Sequencing Data Across Different Species and Conditions
Emilian Jungwirth, Katrin Panzitt, Hanns-Ulrich Marschall, et al.
Studies in Health Technology and Informatics
|
May 24, 2019
A Comprehensive FXR Signaling Atlas Derived from Pooled ChIP-seq Data
Emilian Jungwirth, Katrin Panzitt, Hanns-Ulrich Marschall, et al.
Cancer Letters
|
November 8, 2019
MicroRNA-182-5p regulates hedgehog signaling pathway and chemosensitivity of cisplatin-resistant lung adenocarcinoma cells via targeting GLI2
Carina Seidl, Katrin Panzitt, Alexandra Bertsch, et al.
Journal of Hepatology
|
June 30, 2019
Obeticholic acid may increase the risk of gallstone formation in susceptible patients
Samer Al-Dury, Annika Wahlström, Katrin Panzitt, et al.
Page
of 3